Does GLYCOPYRRONIUM Cause Mobility decreased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Mobility decreased have been filed in association with GLYCOPYRRONIUM (Qbrexza). This represents 0.4% of all adverse event reports for GLYCOPYRRONIUM.
5
Reports of Mobility decreased with GLYCOPYRRONIUM
0.4%
of all GLYCOPYRRONIUM reports
0
Deaths
5
Hospitalizations
How Dangerous Is Mobility decreased From GLYCOPYRRONIUM?
Of the 5 reports, 5 (100.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLYCOPYRRONIUM. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does GLYCOPYRRONIUM Cause?
Mydriasis (280)
Dry mouth (237)
Asthma (227)
Dyspnoea (225)
Vision blurred (182)
Off label use (166)
Drug ineffective (125)
Wheezing (120)
Urinary retention (105)
Cough (103)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which GLYCOPYRRONIUM Alternatives Have Lower Mobility decreased Risk?
GLYCOPYRRONIUM vs GLYCOPYRRONIUM\INDACATEROL
GLYCOPYRRONIUM vs GOLD
GLYCOPYRRONIUM vs GOLD THIOMALATE
GLYCOPYRRONIUM vs GOLIMUMAB
GLYCOPYRRONIUM vs GOLODIRSEN